LTPA2020538I1 - Chinolinonų dariniai ir jų farmacinės kompozicijos - Google Patents

Chinolinonų dariniai ir jų farmacinės kompozicijos

Info

Publication number
LTPA2020538I1
LTPA2020538I1 LTPA2020538C LTPA2020538C LTPA2020538I1 LT PA2020538 I1 LTPA2020538 I1 LT PA2020538I1 LT PA2020538 C LTPA2020538 C LT PA2020538C LT PA2020538 C LTPA2020538 C LT PA2020538C LT PA2020538 I1 LTPA2020538 I1 LT PA2020538I1
Authority
LT
Lithuania
Prior art keywords
pharmaceutical compositions
quinolinone derivatives
quinolinone
derivatives
pharmaceutical
Prior art date
Application number
LTPA2020538C
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0613158A external-priority patent/GB0613158D0/en
Priority claimed from GB0613159A external-priority patent/GB0613159D0/en
Priority claimed from GB0613156A external-priority patent/GB0613156D0/en
Priority claimed from GB0613160A external-priority patent/GB0613160D0/en
Priority claimed from EP06117129A external-priority patent/EP1878722A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LTPA2020538I1 publication Critical patent/LTPA2020538I1/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LTPA2020538C 2006-06-30 2020-12-16 Chinolinonų dariniai ir jų farmacinės kompozicijos LTPA2020538I1 (lt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0613158A GB0613158D0 (en) 2006-06-30 2006-06-30 Organic compounds
GB0613159A GB0613159D0 (en) 2006-06-30 2006-06-30 Organic Compounds
GB0613156A GB0613156D0 (en) 2006-06-30 2006-06-30 Organic Compounds
GB0613160A GB0613160D0 (en) 2006-06-30 2006-06-30 Organic Compounds
EP06117129A EP1878722A1 (en) 2006-07-13 2006-07-13 Quinolinone derivatives and their pharmaceutical compositions
EP07819899A EP2044025B1 (en) 2006-06-30 2007-07-02 Quinolinone derivatives and their pharmaceutical compositions
PCT/EP2007/056632 WO2008000839A1 (en) 2006-06-30 2007-07-02 Quinolinone derivatives and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
LTPA2020538I1 true LTPA2020538I1 (lt) 2021-01-11

Family

ID=38610531

Family Applications (2)

Application Number Title Priority Date Filing Date
LTPA2020535C LTC2044025I2 (lt) 2006-06-30 2020-11-25 Chinolinonų dariniai ir jų farmacinės kompozicijos
LTPA2020538C LTPA2020538I1 (lt) 2006-06-30 2020-12-16 Chinolinonų dariniai ir jų farmacinės kompozicijos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTPA2020535C LTC2044025I2 (lt) 2006-06-30 2020-11-25 Chinolinonų dariniai ir jų farmacinės kompozicijos

Country Status (27)

Country Link
US (2) US8198450B2 (lt)
EP (1) EP2044025B1 (lt)
JP (1) JP5253392B2 (lt)
KR (1) KR101402398B1 (lt)
CN (1) CN101479245B (lt)
AU (1) AU2007264946B2 (lt)
BR (1) BRPI0713951B8 (lt)
CA (1) CA2654801C (lt)
CY (3) CY1113733T1 (lt)
DK (1) DK2044025T3 (lt)
ES (1) ES2396987T3 (lt)
FR (2) FR20C1054I1 (lt)
HK (1) HK1127597A1 (lt)
HR (1) HRP20121074T1 (lt)
HU (2) HUS2000043I1 (lt)
IL (1) IL195796A (lt)
LT (2) LTC2044025I2 (lt)
MA (1) MA30540B1 (lt)
MX (1) MX2008016542A (lt)
MY (1) MY150468A (lt)
NO (3) NO341709B1 (lt)
NZ (1) NZ573292A (lt)
PL (1) PL2044025T3 (lt)
PT (1) PT2044025E (lt)
SI (1) SI2044025T1 (lt)
WO (1) WO2008000839A1 (lt)
ZA (1) ZA200809948B (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012332A1 (en) 1996-09-17 1998-03-26 Chiron Corporation Compositions and methods for treating intracellular diseases
KR20120120453A (ko) 2007-09-05 2012-11-01 화이자 리미티드 Ｎ4-(2,2-다이플루오로-4ｈ-벤조〔1,4〕옥사진-3-온)-6-일〕-5-플루오로-ｎ2-〔3-(메틸아미노카보닐메틸렌옥시)페닐〕2,4-피리미딘다이아민의 지나포에이트 염
JOP20120023B1 (ar) 2011-02-04 2022-03-14 Novartis Ag صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
US20150374623A1 (en) 2013-03-14 2015-12-31 Novartis Ag Deamorphization of spray-dried formulations via spray-blending
US9452139B2 (en) 2013-03-14 2016-09-27 Novartis Ag Respirable agglomerates of porous carrier particles and micronized drug
EP3347345B1 (en) 2015-09-29 2019-07-31 Inke, S.A. Mixed solvate of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1h-quinolin-2-one l-tartrate
CN110724095B (zh) * 2019-09-12 2023-06-09 上海方予健康医药科技有限公司 一种茚达特罗乙酸盐的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05202301A (ja) * 1991-08-29 1993-08-10 Yamamoto Chem Inc ２−アニリノ−３−メチル−６−（Ｎ−ｎ−ブチル−Ｎ−シクロヘキシルアミノ）フルオランの結晶変態、その製造方法及びこの結晶変態を含有する記録材料
EP0688871A3 (en) * 1994-06-24 1998-07-08 Quest International B.V. Preparation of phytosphingosine derivative
FR2777279B1 (fr) * 1998-04-08 2004-08-13 Hoechst Marion Roussel Inc Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
GB0029562D0 (en) 2000-12-04 2001-01-17 Novartis Ag Organic compounds
GB0103926D0 (en) 2001-02-17 2001-04-04 Astrazeneca Ab Chemical compounds
GB0127430D0 (en) 2001-11-15 2002-01-09 Smithkline Beecham Corp Compounds
US7417051B2 (en) 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
GB0303910D0 (en) 2003-02-20 2003-03-26 Merck Sharp & Dohme Therapeutic agents
TWI324150B (en) 2003-02-28 2010-05-01 Novartis Ag Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt
PE20050211A1 (es) 2003-04-02 2005-04-27 Novartis Ag Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas
DE602004019198D1 (de) 2003-04-04 2009-03-12 Novartis Ag Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
JP2005343889A (ja) 2004-05-06 2005-12-15 Taisho Pharmaceut Co Ltd イミダゾピリジン誘導体
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
GB0413960D0 (en) 2004-06-22 2004-07-28 Novartis Ag Organic compounds
AU2006227300B2 (en) 2005-03-21 2012-02-02 Eli Lilly And Company Imidazopyridazine compounds
GB0511065D0 (en) 2005-05-31 2005-07-06 Novartis Ag Organic compounds
EP1910369A1 (en) 2005-07-29 2008-04-16 Astellas Pharma Inc. Fused heterocycles as lck inhibitors

Also Published As

Publication number Publication date
US8198450B2 (en) 2012-06-12
KR101402398B1 (ko) 2014-06-03
JP5253392B2 (ja) 2013-07-31
CN101479245B (zh) 2013-05-22
KR20090023651A (ko) 2009-03-05
ES2396987T3 (es) 2013-03-01
AU2007264946A1 (en) 2008-01-03
MA30540B1 (fr) 2009-06-01
NO2020041I1 (no) 2020-11-23
CA2654801C (en) 2014-08-19
IL195796A (en) 2016-03-31
FR20C1063I1 (fr) 2021-01-22
BRPI0713951A2 (pt) 2012-12-04
IL195796A0 (en) 2009-09-01
PT2044025E (pt) 2012-12-17
NO20090312L (no) 2009-01-28
LTC2044025I2 (lt) 2022-10-10
PL2044025T3 (pl) 2013-02-28
CY2020038I1 (el) 2021-03-12
HUS2000043I1 (hu) 2020-12-28
NO2020044I1 (no) 2020-12-07
CY1113733T1 (el) 2016-06-22
DK2044025T3 (da) 2013-01-14
AU2007264946B2 (en) 2011-01-20
MX2008016542A (es) 2009-01-19
CN101479245A (zh) 2009-07-08
CY2020038I2 (el) 2021-03-12
HUS2000053I1 (hu) 2020-12-28
NO341709B1 (no) 2018-01-02
CY2020041I1 (el) 2021-03-12
CY2020041I2 (el) 2021-03-12
CA2654801A1 (en) 2008-01-03
WO2008000839A1 (en) 2008-01-03
BRPI0713951B1 (pt) 2019-08-13
EP2044025A1 (en) 2009-04-08
FR20C1054I1 (fr) 2020-12-25
EP2044025B1 (en) 2012-10-03
JP2009541455A (ja) 2009-11-26
SI2044025T1 (sl) 2013-01-31
HK1127597A1 (en) 2009-10-02
HRP20121074T1 (hr) 2013-01-31
NZ573292A (en) 2011-03-31
ZA200809948B (en) 2009-05-25
LTPA2020535I1 (lt) 2020-12-28
US20090325912A1 (en) 2009-12-31
BRPI0713951B8 (pt) 2021-05-25
US20120316142A1 (en) 2012-12-13
MY150468A (en) 2014-01-30

Similar Documents

Publication Publication Date Title
LTPA2020538I1 (lt) Chinolinonų dariniai ir jų farmacinės kompozicijos
BRPI0923836A2 (pt) Composições farmacêuticas orais contendo opióide e métodos
BRPI0715712A2 (pt) Composição farmacêutica
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
PL1861387T3 (pl) Pochodne benzoimidazolu i ich kompozycje farmaceutyczne
BRPI0719393A2 (pt) Composição farmacêutica
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
LTPA2018508I1 (lt) Anti-FGF23 antikūnas ir jį apimanti farmacinė kompozicija
BRPI0716445A2 (pt) composiÇço farmacÊutica
PT1861387E (pt) Derivados de benzimidazol e composições farmacêuticas dos mesmos
BRPI0720234A2 (pt) Composição farmacêutica
DK2154966T3 (da) Benzimidazoler og farmaceutiske sammensætninger deraf
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
ATE499368T1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
BRPI0821455A2 (pt) Composições farmacêuticas de amlopidina e valsartan
BRPI0819202A2 (pt) Derivado heterocíclico, e, composição farmacêutica
PT2220047E (pt) Derivados de quinolina, composições farmacêuticas que os contêm e sua utilização
DK2231603T3 (da) Substituerede 3-hydroxypyridiner og farmaceutiske sammensætninger deraf
BRPI0917550A2 (pt) derivado de aminopropilideno e composição farmacêutica compreendendo o referido derivado
TH0801002797A (th) สารประกอบควินอโลน และองค์ประกอบทางเภสัชกรรม
ITRC20060025A1 (it) Composizione farmaceutica
ITRC20060024A1 (it) Composizione farmaceutica
ITMI20061734A1 (it) Composizione farmaceutica